THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry [PDF]
, 2017 Axel Finckh +12 more
openalex +1 more source
Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases? [PDF]
J Clin MedMısırcı S +6 more
europepmc +1 more source
A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers [PDF]
, 2013 Bernard Ng, Adeline Chu, Myrna M. Khan
openalex +1 more source
Association of disease-modifying antirheumatic drug selection with hospitalised infection among youth with childhood-onset systemic lupus erythematosus. [PDF]
Lupus Sci MedRoberts JE +12 more
europepmc +1 more source
Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents [PDF]
, 2014 Meliha C Kapetanovic
openalex +1 more source
Perception of COVID-19 vaccines in rheumatology patients. [PDF]
Medicine (Baltimore)Romero-Bogado L +16 more
europepmc +1 more source
Preterm birth in women with psoriatic arthritis: what are the risks and risk factors? A collaborative cohort study from Sweden, Denmark and Norway. [PDF]
RMD OpenSecher AEP +7 more
europepmc +1 more source
Pharmacokinetics of Carfenil, an antirheumatic agent in patients with renal insufficiency.
, 1988 Akira Okazaki
openalex +2 more sources
Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune diseases: a disproportionality study based on FAERS and VigiAccess. [PDF]
Front PharmacolZhang X +7 more
europepmc +1 more source